Shares in MDMG, the largest Russian player in obs, gynae and paediatrics have crashed 70% since its listing on the London Stock Exchange in 2012, yet there doesn’t seem a lot wrong with the half year results with sales up 36% at RUB 4.52bn ($70m) and EBITDA ahead 29% at RUB 1.25bn ($20m) in the first half of 2015. Kurtser, once chief obstetrician and gynaecologist of the city of Moscow and the go-to-doctor for the Russian elite, has built the business from scratch and still owns 68%.